BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
60 results:

  • 1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
    Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
    JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Robotic transperitoneal versus retroperitoneal approach for anterior renal mass nephron-sparing surgery.
    Lanzotti NJ; Felice M; Janakiraman S; Lewer O; James C; Ellis JL; Rac G; Patel HD; Gupta GN
    J Robot Surg; 2024 Feb; 18(1):75. PubMed ID: 38353825
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway.
    Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G
    Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ureteral Stents Do Not Increase the Risk for Acute kidney Injury After Colorectal Surgery.
    Schmied ID; Rajkumar D; Chang MI; Colom SM; Cleary RK
    Dis Colon Rectum; 2024 Jan; 67(1):151-159. PubMed ID: 37678267
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diffusion-weighted and diffusion kurtosis imaging analysis of microstructural differences in clear cell renal cell carcinoma: a comparative study.
    Zou J; Ye J; Zhu W; Wu J; Chen W; Chen R; Zhu Q
    Br J Radiol; 2023 Oct; 96(1150):20230146. PubMed ID: 37393526
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.
    Babajani A; Rahmani S; Raoufi M; Eidgahi ES; Dastjerdi AV; Behfarnia P; Khalili S; Moghaddam NA
    Front Endocrinol (Lausanne); 2023; 14():1135196. PubMed ID: 37313444
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
    Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
    Br J Sports Med; 2023 Aug; 57(15):979-989. PubMed ID: 36854652
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of ST3GAL5 as a prognostic biomarker correlating with CD8
    Liu J; Li M; Wu J; Qi Q; Li Y; Wang S; Liang S; Zhang Y; Zhu Z; Huang R; Yan J; Zhu R
    Front Immunol; 2022; 13():979605. PubMed ID: 36172374
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma.
    Li K; Li Y; Lyu Y; Tan L; Zheng X; Jiang H; Wen H; Feng C
    Front Immunol; 2022; 13():853088. PubMed ID: 35651604
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Shifting role of cytoreductive nephrectomy according to type of systemic therapy: A nationwide cohort study.
    Choi SY; Ha MS; Lee JW; Kim JH; Kim JH; Chi BH; Kim JW; Chang IH; Kim TH; Myung SC
    Asian J Surg; 2023 Jan; 46(1):328-336. PubMed ID: 35450758
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.
    Wang X; Zhang J; Wang Y; Wang Y; Yu W; Shi G
    Am J Med Sci; 2022 Aug; 364(2):220-228. PubMed ID: 35289275
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma.
    Tang C; Qu G; Xu Y; Yang G; Wang J; Xiang M
    Aging (Albany NY); 2021 Dec; 13(24):26046-26062. PubMed ID: 34954690
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.
    Dawoud AAZ; Gilbert RD; Tapper WJ; Cross NCP
    Leukemia; 2022 Feb; 36(2):507-515. PubMed ID: 34413458
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association of Preoperative Prognostic Nutritional Index and Postoperative Acute kidney Injury in Patients with Colorectal Cancer Surgery.
    Sim JH; Bang JY; Kim SH; Kang SJ; Song JG
    Nutrients; 2021 May; 13(5):. PubMed ID: 34064893
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
    Weidle UH; Nopora A
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Matsumura-Nakano Y; Nakatsuma K; Watanabe H; Yamamoto E; Kato E; Fuki M; Yamaji K; Nishikawa R; Nagao K; Takeji Y; Watanabe H; Tazaki J; Watanabe S; Saito N; Yamazaki K; Soga Y; Komiya T; Ando K; Minatoya K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Am J Cardiol; 2021 Mar; 142():35-43. PubMed ID: 33279479
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acquired Cystic kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.
    Shah A; Lal P; Toorens E; Palmer MB; Schwartz L; Vergara N; Guzzo T; Nayak A
    Am J Surg Pathol; 2020 Nov; 44(11):1479-1486. PubMed ID: 32604168
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. c-cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth.
    Lyle C; Richards S; Yasuda K; Napoleon MA; Walker J; Arinze N; Belghasem M; Vellard I; Yin W; Ravid JD; Zavaro E; Amraei R; Francis J; Phatak U; Rifkin IR; Rahimi N; Chitalia VC
    Sci Rep; 2019 Dec; 9(1):20257. PubMed ID: 31882749
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.